AR069166A1 - Derivados de 1,3- dihidro-5- isobenzofurancarbonitrilo, composicion farmaceutica de los mismos para el tratamiento de la eyaculacion precoz prematura y procedimiento para obtener dichos productos - Google Patents

Derivados de 1,3- dihidro-5- isobenzofurancarbonitrilo, composicion farmaceutica de los mismos para el tratamiento de la eyaculacion precoz prematura y procedimiento para obtener dichos productos

Info

Publication number
AR069166A1
AR069166A1 ARP080104804A ARP080104804A AR069166A1 AR 069166 A1 AR069166 A1 AR 069166A1 AR P080104804 A ARP080104804 A AR P080104804A AR P080104804 A ARP080104804 A AR P080104804A AR 069166 A1 AR069166 A1 AR 069166A1
Authority
AR
Argentina
Prior art keywords
thienyl
pharmaceutical composition
treatment
derivatives
ejaculation
Prior art date
Application number
ARP080104804A
Other languages
English (en)
Original Assignee
Dong A Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong A Pharm Co filed Critical Dong A Pharm Co
Publication of AR069166A1 publication Critical patent/AR069166A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

También se describe una composicion farmacéutica para tratar o prevenir eyaculacion prematura que incluye el compuesto. Los derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo tienen una vida media corta e inhiben el proceso de eyaculacion inhibiendo selectivamente la recaptacion de serotonina por medio de un transportador de recaptacion de serotonina presente en una neurona presináptica. Por consiguiente, los compuestos son utiles en el tratamiento y prevencion de la eyaculacion prematura. Reivindicacion 1: Un derivado representado por la formula 1 o su sal aceptable para uso farmacéutico, donde, R1 es un fenilo sustituido o no sustituido, o heterociclilo seleccionado entre piridinilo, isoxazolilo, tiazolilo, pirimidinilo, indanilo, benztiazolilo, pirazolilo, tiadiazolilo, oxazolilo, piperidinilo, morfolinilo, imidazolilo, pirrolidinilo, tienilo, triazolilo, pirrolilo y furilo; R2 es dialquilamino C1-6, o un heterociclilo sustituido o no sustituido seleccionado entre piridinilo, isoxazolilo, tiazolilo, pirimidinilo, indanilo, benztiazolilo, pirazolilo, tiadiazolilo, oxazolilo, piperidinilo, morfolinilo, imidazolilo, pirrolidinilo, tienilo, triazolilo, pirrolilo y furilo; y n es un numero entero de 1 a 3.
ARP080104804A 2007-11-02 2008-11-03 Derivados de 1,3- dihidro-5- isobenzofurancarbonitrilo, composicion farmaceutica de los mismos para el tratamiento de la eyaculacion precoz prematura y procedimiento para obtener dichos productos AR069166A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20070111783 2007-11-02
KR1020080105439A KR101103118B1 (ko) 2007-11-02 2008-10-27 신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물

Publications (1)

Publication Number Publication Date
AR069166A1 true AR069166A1 (es) 2010-01-06

Family

ID=40855892

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080104804A AR069166A1 (es) 2007-11-02 2008-11-03 Derivados de 1,3- dihidro-5- isobenzofurancarbonitrilo, composicion farmaceutica de los mismos para el tratamiento de la eyaculacion precoz prematura y procedimiento para obtener dichos productos

Country Status (20)

Country Link
US (1) US8242159B2 (es)
EP (1) EP2215070A4 (es)
JP (1) JP5281649B2 (es)
KR (1) KR101103118B1 (es)
CN (1) CN101910146A (es)
AR (1) AR069166A1 (es)
AU (1) AU2008319628B2 (es)
BR (1) BRPI0818267A2 (es)
CA (1) CA2703783C (es)
CL (1) CL2008003231A1 (es)
CO (1) CO6280531A2 (es)
IL (1) IL205350A0 (es)
MX (1) MX2010004727A (es)
NZ (1) NZ585091A (es)
PE (1) PE20091018A1 (es)
RU (1) RU2448963C2 (es)
TW (1) TWI365741B (es)
UA (1) UA99492C2 (es)
WO (1) WO2009057974A2 (es)
ZA (1) ZA201003794B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013026455A1 (en) * 2011-08-24 2013-02-28 Aarhus Universitet Permanently positively charged antidepressants
US9169237B1 (en) * 2014-10-24 2015-10-27 Medi Synergics, LLC Antiprotozoal amidine compounds
KR101637177B1 (ko) * 2014-03-14 2016-07-07 건일제약 주식회사 8-히드록시클로미프라민 또는 이의 약학적으로 허용가능한 염의 제조방법
SG11201706515QA (en) 2015-02-11 2017-09-28 Sunovion Pharmaceuticals Inc 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders
EA201990400A1 (ru) 2016-07-29 2019-07-31 Суновион Фармасьютикалз, Инк. Соединения и композиции и их применение
MA45795A (fr) 2016-07-29 2019-06-05 Sunovion Pharmaceuticals Inc Composés et compositions, et utilisations associées
EP3661929B1 (en) 2017-08-02 2021-07-14 Sunovion Pharmaceuticals Inc. Isochroman compounds and uses thereof
CN109111415B (zh) * 2018-10-25 2022-08-23 安徽中医药大学 一类石斛生物碱衍生物、制备方法和医药用途
US11136304B2 (en) 2019-03-14 2021-10-05 Sunovion Pharmaceuticals Inc. Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
EP1397126B9 (en) * 2001-03-16 2007-02-21 DMI Biosciences, Inc. Use of tramadol for delaying ejaculation
EP1446396A1 (en) * 2001-11-08 2004-08-18 Sepracor, Inc. Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
IN192863B (es) 2001-11-13 2004-05-22 Ranbaxy Lab Ltd
US6764200B1 (en) * 2003-01-15 2004-07-20 Hsiang Lan Wu Liu Decorative lantern
JP4667369B2 (ja) * 2003-03-21 2011-04-13 ネックスメド ホールディングス インコーポレイテッド 早漏を治療するための組成物および方法
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds

Also Published As

Publication number Publication date
EP2215070A4 (en) 2011-11-02
EP2215070A2 (en) 2010-08-11
RU2010122320A (ru) 2011-12-10
JP2011502981A (ja) 2011-01-27
CL2008003231A1 (es) 2009-11-27
WO2009057974A3 (en) 2009-07-16
US20100240725A1 (en) 2010-09-23
KR101103118B1 (ko) 2012-01-04
KR20090045855A (ko) 2009-05-08
JP5281649B2 (ja) 2013-09-04
ZA201003794B (en) 2011-02-23
MX2010004727A (es) 2010-05-20
TW200934481A (en) 2009-08-16
PE20091018A1 (es) 2009-08-17
CN101910146A (zh) 2010-12-08
CA2703783A1 (en) 2009-05-07
CO6280531A2 (es) 2011-05-20
US8242159B2 (en) 2012-08-14
AU2008319628B2 (en) 2012-03-29
IL205350A0 (en) 2010-12-30
RU2448963C2 (ru) 2012-04-27
CA2703783C (en) 2012-12-04
TWI365741B (en) 2012-06-11
WO2009057974A2 (en) 2009-05-07
NZ585091A (en) 2012-04-27
AU2008319628A1 (en) 2009-05-07
BRPI0818267A2 (pt) 2015-04-14
UA99492C2 (ru) 2012-08-27

Similar Documents

Publication Publication Date Title
AR069166A1 (es) Derivados de 1,3- dihidro-5- isobenzofurancarbonitrilo, composicion farmaceutica de los mismos para el tratamiento de la eyaculacion precoz prematura y procedimiento para obtener dichos productos
Taha et al. Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities
NO20085060L (no) Triazolpyrazinderivater anvendelige som anti-cancermidler
EA200900066A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил) -d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
AR061666A1 (es) Derivados de bencimidazol, metodo de produccion de los mismos y preparaciones farmaceuticas que los contienen
PA8683501A1 (es) Derivados de isoquinolina
DOP2007000079A (es) Compuestos fenil amido heterocíclicos condensados
AR060675A1 (es) Derivados de n-(2-tiazolil)-amida como inhibidores de gsk-3,metodo de preparacion, composiciones farmaceuticas que los contienen,y usos terapeuticos.
NO20055688L (no) Organiske forbindelser
CY1115058T1 (el) Παραγωγα 1,2,3- τριαζολης για χρηση ως αναστολεις στεατοϋλο-coa δεσατουρασης
MX2008002061A (es) Derivados de tiazolil piperidina utiles como moduladores del receptor h3.
AR067770A1 (es) Derivados de tiazol y ditiazol para el tratamiento de diabetes
UA115806C2 (uk) Похідні доластатину 10 та ауристатинів
BR112013025275A2 (pt) derivados de cefalosporina e suas composições farmacêuticas
AR074801A1 (es) Monocarbamas y composiciones farmaceuticas que los contienen
AR090879A1 (es) Acidos indanoiloxidihidrobenzofuranilaceticos
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
CY1112191T1 (el) Παραγωγο πυραζολοπυριμιδινης
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
DE602005014629D1 (de) Pyrazolphenylderivate als ppar-aktivatoren
CY1111129T1 (el) Στερεη φαρμακευτικη ενωση που περιεχει τελιθρομυκινη
AR077429A1 (es) Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos
NO20080860L (no) Substituert propanamidderivat og farmasoytisk preparat som inneholder dette
AR057403A1 (es) 4- anilino-3-quinolincarbonitrilos para el tratamiento del cancer
EA201000832A1 (ru) Замещённые 3-гидроксипиридины и содержащие их фармацевтические композиции

Legal Events

Date Code Title Description
FA Abandonment or withdrawal